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Abstract 
Brenner tumors comprise an uncommon 
subtype of the surface epithelial-stromal tumor 
group of ovarian neoplasms. While most are 
benign, some can be malignant, and we report such 
a case and its treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Brenner tumours were first described by 
MacNoughton Jones in 1898 in his paper ‘Uterine 
fibroid with anomalous ovarian tumour.’1 In 1907, 
Fritz Brenner published his article ‘Des oophorona 
folliculare’ because of the resemblance of the 
epithelioid nests that Brenner found in his tumour, 
to Graafian follicles.2 The semblance to Graafian 
follicles underpinned Fritz Brenner’s classification 
of Brenner tumours as a variant of granulosa cell 
tumour.  In 1932, Meyer, revisited the topic of 
Brenner tumours and clarified that they are different 
from granulosa cell tumours.3 However, Brenner 
became aware of such a publication, 24 years later 
and did not publish any other articles on this 
subject.  
The incidence of ovarian cancer is 11.7 per 
100,000 women per year.4 Ovarian Brenner 
tumours represent a rare epithelial ovarian 
neoplasm accounting for approximately 1–2% of all 
ovarian tumours. Brenner tumours can be sub-
classified into benign, borderline or malignant 
variants.5 Malignant Brenner tumours are extremely 
rare, comprising less than 5% of all Brenner 
tumours. Malignant Brenner tumour was first 
reported in 1945 by von Numeras.6 
A 70-year-old lady was referred by her family 
doctor with a large abdominal mass associated with 
a 19-kilo weight loss  over 3 months, and 1-month 
history of constipation. General examination 
revealed a large hard mass, extending up to the 
umbilicus. An ultrasound scan showed a pelvic 
mass, probably of ovarian origin. Her Risk of 
Malignancy Index (RMI) score, which is calculated 
as the product of the ultrasound findings score, 
menopausal status and ca125 levels, added up to 
1580. This was followed by computed tomographic 
assessment of the trunk, which revealed a large 
inhomogeneous mass measuring 16cm by 14cm by 
17cm, originating from the pelvic cavity, with 
enlarged pelvic lymph nodes, together with an ill-
defined hypovascular nodule measuring 8mm in 
diameter in the liver. The pelvic mass was further 
characterised by magnetic resonance imaging and 
was found to be arising from the left ovary. 
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Multiple peritoneal metastases and ascites were also 
seen. The liver was further studied by magnetic 
resonance imaging, which showed two 
indeterminate lesions in the right hepatic lobe. 
Ultrasound guided biopsy of the liver lesion was 
then performed. A core biopsy was obtained from 
the larger lesion and the histological and the 
immune-histochemical findings revealed metastatic 
carcinoma of urothelial nature. The 
immunohistochemistry profile was positive for 
BRCK, CK7, p63 and p53. It was inhibin and 
oestrogen receptor negative.  
Total abdominal hysterectomy with bilateral 
salpingo-oophorectomy and omentectomy were 
performed via a midline laparotomy. Intra- 
operatively, an 18 cm-left ovarian tumour was 
found illustrated in Figure 1. On cross section, the 
mass showed a partly solid ossified tissue and partly 
cystic lesion.  On sectioning of the cystic 
component, a multi-cystic lesion filled with thick 
yellowish fluid and multiple papillary structures 
were visible on the inner surface.  
 
Figure 1: Image showing the left smooth adnexal 
mass measuring 20cm by 13.5cm by 12.5cm.  
The fallopian tube is also visible, measuring 9cm by 
3cm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The histological result confirmed a malignant 
Brenner tumour limited to the ovary, with 
angiolymphatic invasion (figure 2), pT1c3NxM1b, 
FIGO IVB.  
Histologically, the left ovarian tumour was 
composed of sheets and nests of urothelial cells 
with intra-tumour micro cyst formation. Fused 
papillary fronds were focally identified projecting 
into the cyst lumina. Stromal desmoplasia was 
identified in areas, associated with focal dystrophic 
calcification and ossification. The urothelial cells 
showed mild-to-moderate nuclear pleomorphism 
and were briskly mitotically active as shown in 
figure 3. Areas of intra-tumoural necrosis were 
present. 
The other ovary, uterus and cervix showed no 
evidence of involvement by tumour.  
The case was discussed at the Gynaecology 
Multidisciplinary Team Meeting and the patient 
was referred for further oncological care. The 
patient is currently receiving six cycles of adjuvant 
paclitaxel and cisplatin at 3-weekly intervals.  
 
Figure 2: Image illustrating vascular invasion of 
tumour cells. 
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Figure 3: Image illustrating actively dividing cell 
and prominent nuclei within cells. 
 
 
 
 
 
 
 
 
Hull and Campbell, in 1973, have proposed 
that a set of histological criteria should be present to 
diagnose malignant Brenner tumour. This requires 
the presence of malignant histological features 
forming irregular epithelial nests, benign or 
borderline Brenner tumour elements and stromal 
invasion.7 
The prognosis of such malignancies is 
relatively poor in view of late presentation and 
rarity of the disease.  In a number of case reports 
published by Yomomato et al. in 1999 8, the tumour 
marker Ca72-4, was raised in both cases studied. 
Further studies need to clarify the validity of such a 
tumour marker. Ca125 can be used to monitor 
response to treatment and degree of disease burden, 
however, its use as a screening marker in Brenner 
tumours remains unclear.  
In an analysis of 13 cases of malignant 
Brenner tumours, Gezginc et al. 9, found that the 
overall mortality was 50%, with a mean survival 
time post-diagnosis of 1 year. Surgery remains the 
mainstay of treatment in these cases. However, 
since malignant Brenner tumours are rare, 
management relies on published case reports and 
remains poorly defined. 
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